Cargando…
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation
OBJECTIVE: To evaluate the efficacy in smoking cessation and safety of 2 and 4 mg nicotine mint lozenges in Chinese adult smokers. METHODS: This was a multicenter, randomized, stratified, double-blind, placebo-controlled, parallel-group study. The low-dependence stratum included 483 smokers (241 ran...
Autores principales: | Xiao, Dan, Kotler, Mitchell, Kang, Jian, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012347/ https://www.ncbi.nlm.nih.gov/pubmed/31658113 http://dx.doi.org/10.1097/ADM.0000000000000547 |
Ejemplares similares
-
Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
por: Sukhija, Manpreet, et al.
Publicado: (2018) -
Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler
por: Kralikova, Eva, et al.
Publicado: (2009) -
The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial
por: Gobarani, Rukshar Kaizerali, et al.
Publicado: (2020) -
Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge
por: Nelson, Paul R, et al.
Publicado: (2019) -
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell(®))
por: Dautzenberg, Bertrand, et al.
Publicado: (2007)